Literature DB >> 17964023

Advances in brain tumor surgery.

Ashok R Asthagiri1, Nader Pouratian, Jonathan Sherman, Galal Ahmed, Mark E Shaffrey.   

Abstract

Advances in the fields of molecular and translational research, oncology, and surgery have emboldened the medical community to believe that intrinsic brain tumors may be treatable. Intraoperative imaging and brain mapping allow operations adjacent to eloquent cortex and more radical resection of tumors with increased confidence and safety. Despite these advances, the infiltrating edge of a neoplasm and distant microscopic satellite lesions will never be amendable to a surgical cure. Indeed, it is continued research into the delivery of an efficacious chemobiologic agent that will eventually allows us to manage this primary cause of treatment failure.

Entities:  

Mesh:

Year:  2007        PMID: 17964023     DOI: 10.1016/j.ncl.2007.07.006

Source DB:  PubMed          Journal:  Neurol Clin        ISSN: 0733-8619            Impact factor:   3.806


  23 in total

Review 1.  Neural stem cell therapy for cancer.

Authors:  Juli Rodriguez Bagó; Kevin T Sheets; Shawn D Hingtgen
Journal:  Methods       Date:  2015-08-24       Impact factor: 3.608

2.  Adult glioblastoma multiforme survival in the temozolomide era: a population-based analysis of Surveillance, Epidemiology, and End Results registries.

Authors:  Amy S Darefsky; Joseph T King; Robert Dubrow
Journal:  Cancer       Date:  2011-08-31       Impact factor: 6.860

3.  Temozolomide delivery to tumor cells by a multifunctional nano vehicle based on poly(β-L-malic acid).

Authors:  Rameshwar Patil; José Portilla-Arias; Hui Ding; Satoshi Inoue; Bindu Konda; Jinwei Hu; Kolja A Wawrowsky; Paul K Shin; Keith L Black; Eggehard Holler; Julia Y Ljubimova
Journal:  Pharm Res       Date:  2010-04-13       Impact factor: 4.200

4.  Tumor Resection Recruits Effector T Cells and Boosts Therapeutic Efficacy of Encapsulated Stem Cells Expressing IFNβ in Glioblastomas.

Authors:  Sung Hugh Choi; Daniel W Stuckey; Sara Pignatta; Clemens Reinshagen; Jasneet Kaur Khalsa; Nicolaas Roozendaal; Jordi Martinez-Quintanilla; Kaoru Tamura; Erhan Keles; Khalid Shah
Journal:  Clin Cancer Res       Date:  2017-09-14       Impact factor: 12.531

5.  Engineering toxin-resistant therapeutic stem cells to treat brain tumors.

Authors:  Daniel W Stuckey; Shawn D Hingtgen; Nihal Karakas; Benjamin E Rich; Khalid Shah
Journal:  Stem Cells       Date:  2015-02       Impact factor: 6.277

6.  Time trends in glioblastoma multiforme survival: the role of temozolomide.

Authors:  Robert Dubrow; Amy S Darefsky; Daniel I Jacobs; Lesley S Park; Michal G Rose; Maxwell S H Laurans; Joseph T King
Journal:  Neuro Oncol       Date:  2013-09-17       Impact factor: 12.300

7.  A single-institution restrospective experience of brachytherapy in the treatment of pituitary tumors: transsphenoidal approach combined with (192)Ir-afterloading catheters.

Authors:  A Di Mambro; C Giuliani; F Ammannati; E Mannucci; S Scoccianti; B Detti; I Meattini; P Mennonna; G Forti; M Serio; A Peri
Journal:  J Endocrinol Invest       Date:  2009-12-01       Impact factor: 4.256

8.  Label-Free Neurosurgical Pathology with Stimulated Raman Imaging.

Authors:  Fa-Ke Lu; David Calligaris; Olutayo I Olubiyi; Isaiah Norton; Wenlong Yang; Sandro Santagata; X Sunney Xie; Alexandra J Golby; Nathalie Y R Agar
Journal:  Cancer Res       Date:  2016-04-12       Impact factor: 12.701

9.  Real-time multi-modality imaging of glioblastoma tumor resection and recurrence.

Authors:  Shawn Hingtgen; Jose-Luiz Figueiredo; Christian Farrar; Matthias Duebgen; Jordi Martinez-Quintanilla; Deepak Bhere; Khalid Shah
Journal:  J Neurooncol       Date:  2012-12-16       Impact factor: 4.130

10.  Radiotherapy and concomitant temozolomide during the first and last weeks in high grade gliomas: long-term analysis of a phase II study.

Authors:  Mario Balducci; Giuseppe Roberto D'Agostino; Stefania Manfrida; Filippo De Renzi; Gabriella Colicchio; Giuseppina Apicella; Annunziato Mangiola; Alba Fiorentino; Vincenzo Frascino; Giovanna Mantini; Berardino De Bari; Angelo Pompucci; Vincenzo Valentini; Carmelo Anile; Numa Cellini
Journal:  J Neurooncol       Date:  2009-08-25       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.